664 related articles for article (PubMed ID: 16082890)
1. [Beta-lactamases in laboratory and their role in resistance Part I.: Evolution of bacterial resistance mediated by beta-lactamases].
Bedenić B
Lijec Vjesn; 2004; 126(11-12):314-24. PubMed ID: 16082890
[TBL] [Abstract][Full Text] [Related]
2. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
3. [Beta-lactamases and their role in resistance. PART 2: beta-lactamases in 21st century].
Bedenić B
Lijec Vjesn; 2005; 127(1-2):12-21. PubMed ID: 16145868
[TBL] [Abstract][Full Text] [Related]
4. [Clinically important beta-lactamases of gram-negative bacteria: extended-spectrum beta-lactamases (ESBL)].
Hrabák J
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):103-11. PubMed ID: 17900058
[TBL] [Abstract][Full Text] [Related]
5. Extended-spectrum beta-lactamases: an actual problem of hospital microbiology (a review).
Szabó D; Barcs I; Rozgonyi F
Acta Microbiol Immunol Hung; 1997; 44(4):309-25. PubMed ID: 9554165
[TBL] [Abstract][Full Text] [Related]
6. The evolution of beta-lactamases.
Bush K
Ciba Found Symp; 1997; 207():152-63; discussion 163-6. PubMed ID: 9189640
[TBL] [Abstract][Full Text] [Related]
7. What's new in antibiotic resistance? Focus on beta-lactamases.
Babic M; Hujer AM; Bonomo RA
Drug Resist Updat; 2006 Jun; 9(3):142-56. PubMed ID: 16899402
[TBL] [Abstract][Full Text] [Related]
8. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases.
Shah AA; Hasan F; Ahmed S; Hameed A
Res Microbiol; 2004; 155(6):409-21. PubMed ID: 15249058
[TBL] [Abstract][Full Text] [Related]
9. Bactericidal activity of oral beta-lactam antibiotics in plasma and urine versus isogenic Escherichia coli strains producing broad- and extended-spectrum beta-lactamases.
Bedenic B; Vranes J; Suto S; Zagar Z
Int J Antimicrob Agents; 2005 Jun; 25(6):479-87. PubMed ID: 15894465
[TBL] [Abstract][Full Text] [Related]
10. Minor extended-spectrum beta-lactamases.
Naas T; Poirel L; Nordmann P
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():42-52. PubMed ID: 18154527
[TBL] [Abstract][Full Text] [Related]
11. [Broad-spectrum beta-lactamases in Gram-negative bacteria].
Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O
Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424
[TBL] [Abstract][Full Text] [Related]
12. Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases.
Pfaller MA; Segreti J
Clin Infect Dis; 2006 Apr; 42 Suppl 4():S153-63. PubMed ID: 16544266
[TBL] [Abstract][Full Text] [Related]
13. [Appearance of extended-spectrum beta-lactamases].
Iyobe S
Nihon Rinsho; 1997 May; 55(5):1219-24. PubMed ID: 9155178
[TBL] [Abstract][Full Text] [Related]
14. [Extended spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae].
Bedenić B
Lijec Vjesn; 1996 Oct; 118(10):244-8. PubMed ID: 9132524
[TBL] [Abstract][Full Text] [Related]
15. New beta-lactamases: a paradigm for the rapid response of bacterial evolution in the clinical setting.
Rossolini GM; Docquier JD
Future Microbiol; 2006 Oct; 1(3):295-308. PubMed ID: 17661642
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002.
Moland ES; Hanson ND; Black JA; Hossain A; Song W; Thomson KS
J Clin Microbiol; 2006 Sep; 44(9):3318-24. PubMed ID: 16954267
[TBL] [Abstract][Full Text] [Related]
17. [Effect of broad spectrum beta-lactamases on in vitro sensitivity of clinical isolates of Klebsiella pneumoniae to oral cephalosporins].
Bedenić B; Singer S
Lijec Vjesn; 2000; 122(1-2):8-13. PubMed ID: 10916350
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
19. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens.
Pfeifer Y; Cullik A; Witte W
Int J Med Microbiol; 2010 Aug; 300(6):371-9. PubMed ID: 20537585
[TBL] [Abstract][Full Text] [Related]
20. Fluorescein-labeled beta-lactamase mutant for high-throughput screening of bacterial beta-lactamases against beta-lactam antibiotics.
Chan PH; Chan KC; Liu HB; Chung WH; Leung YC; Wong KY
Anal Chem; 2005 Aug; 77(16):5268-76. PubMed ID: 16097768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
